Global Health Limited (NSE:MEDANTA)
India · Delayed Price · Currency is INR 1,357.00
-8.00 (-0.59%)
Oct 1, 2026, 3:29 PM IST
Global Health Stock Forecast
Stock Price Forecast
According to 19 analysts polled by S&P Global, Global Health stock has a consensus rating of "Buy" and an average price target of ₹1,598. The average 1-year stock price forecast is 17.74% higher than the current stock price, while the lowest is ₹1,410 (+3.91%) and the highest is ₹1,799 (+32.57%).
Price Target: ₹1,598 (+17.74%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Aug 4, 2026.
Analyst Ratings
The average analyst rating for Global Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 11 | 11 | 11 | 10 | 11 |
| Buy | 4 | 4 | 4 | 4 | 6 | 6 |
| Hold | 4 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 17 | 17 | 17 | 18 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains ₹1,500 → ₹1,660 | Buy | Maintains | ₹1,500 → ₹1,660 | +22.33% | Aug 4, 2026 |
Financial Forecast
Revenue This Year
53.14B
from 44.10B
Increased by 20.49%
Revenue Next Year
61.34B
from 53.14B
Increased by 15.44%
EPS This Year
26.75
from 20.69
Increased by 29.30%
EPS Next Year
33.63
from 26.75
Increased by 25.71%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.